DrugPatentWatch Database Preview
Email this page to a colleague» See Plans and Pricing
« Back to Dashboard
Flurazepam Hydrochloride is a drug marketed by Aurolife Pharma Llc, Halsey, Heritage Pharma, Hikma Intl Pharms, Hikma Pharms, Mylan Pharms Inc, Par Pharm, Purepac Pharm, Sun Pharm Industries, Superpharm, Usl Pharma, and Warner Chilcott. and is included in twenty-two NDAs.
The generic ingredient in FLURAZEPAM HYDROCHLORIDE is flurazepam hydrochloride. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the flurazepam hydrochloride profile page.
A generic version of FLURAZEPAM HYDROCHLORIDE was approved as flurazepam hydrochloride by MYLAN PHARMS INC on November 27th, 1985.
Recent Clinical Trials for FLURAZEPAM HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
|Saint-Joseph University||Phase 3|
|Eisai Inc.||Phase 1|
|Hannover Medical School||Phase 3|
Pharmacology for FLURAZEPAM HYDROCHLORIDE
|Drug Class||Benzodiazepine |